Skip to main content
. Author manuscript; available in PMC: 2012 Jun 8.
Published in final edited form as: Integr Cancer Ther. 2011 Aug 5;11(2):83–89. doi: 10.1177/1534735411413262

Table 3.

Association of vitamin and supplement (VS) use with demographic characteristics among unaffected brothers of men with prostate cancer (n=542). Models are adjusted for age at time of survey.*

Currently Using
Any VS
OR (95% CI)
Currently Using
only Vitamins
OR(95% CI)
Currently Using
VS (excluding
MV)
OR (95% CI)
Currently Using
Prostate-
Related VS
OR (95% CI)

Age at time of survey (yr) 1.03 (1.01–1.05) 1.03 (1.01–1.05) 1.04 (1.02–1.06) 1.04 (1.02–1.07)

Younger age at survey compared to brother’s age at diagnosis* 1.03 (0.69–1.53) 0.90 (0.60–1.33) 1.33 (0.88–2.00) 1.22 (0.80–1.86)

Birth Order*
     Younger 1.30 (0.89–1.91) 1.20 (0.83–1.74) 1.61 (1.09–2.39) 1.51 (1.01–2.25)
     Older 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)

Marital status*
     Married 1.04 (0.65–1.68) 0.97 (0.60–1.55) 1.22 (0.73–2.03) 1.30 (0.77–2.22)
     Not married 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)

Education *
     ≥ 16 years 1.25 (0.89–1.77) 1.23 (0.88–1.74) 1.27 (0.89–1.81) 1.20 (0.83–1.73)
     < 16 years 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)

Income*
     ≥$75,000 1.33 (0.94–1.90) 1.28 (0.90–1.81) 1.10 (0.77–1.59) 1.03 (0.71–1.49)
     <$75,000 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)

Number of first degree affecteds*
     ≥ 2 1.24 (0.87–1.75) 1.25 (0.89–1.77) 1.27 (0.89–1.83) 1.24 (0.85–1.79)
     1 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)

Number of first degree affecteds*(continuous) 1.11 (0.90–1.37) 1.13 (0.92–1.39) 1.11 (0.91–1.37) 1.12 (0.91–1.39)

Smoking status*
     Smoker 1.00 (0.71–1.42) 0.99 (0.70–1.39) 0.93 (0.65–1.33) 0.93 (0.64–1.34)
     Non-Smoker 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
*

Models are adjusted for age at time of survey.

HHS Vulnerability Disclosure